Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for kids with short bowel syndrome: can a daily shot reduce the need for IV nutrition?

NCT ID NCT07319832

First seen Jan 09, 2026 · Last updated May 19, 2026 · Updated 17 times

Summary

This study looks at how well the drug teduglutide works for children aged 1 to 17 with short bowel syndrome who rely on IV nutrition. The goal is to see if the drug can reduce the amount of IV nutrition they need, and possibly help some stop it entirely. Researchers will review medical records and collect new data over 24 weeks. The study is currently recruiting 12 participants in China.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME (SBS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Hospital Zhejiang University School of Medicine

    NOT_YET_RECRUITING

    Hangzhou, Zhejiang, 310006, China

    Contact

  • Guangzhou Women And Children's Medical Center

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510040, China

    Contact

  • Shanghai Children's Hospital

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, 200062, China

    Contact

  • Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    RECRUITING

    Shanghai, Shanghai Municipality, 200092, China

    Contact

Conditions

Explore the condition pages connected to this study.